Biotest AG (DE:BIO)
XETRA:BIO
Holding DE:BIO?
Track your performance easily

Biotest (BIO) Balance Sheet

3 Followers

Biotest Balance Sheet

Biotest's total assets for Q4 2022 were €1.20B, an increase of 11.46% from the previous quarter. DE:BIO total liabilities were €― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
€ 1.20B€ 1.10B€ 1.13B€ 1.11B€ 1.04B
Total Liabilities
-----
Total Equity Gross Minority
€ 371.10M€ 380.40M€ 441.60M€ 476.90M€ 495.20M
Total Capitalization
€ 911.60M€ 848.30M€ 879.80M€ 856.50M€ 820.60M
Preferred Stock Equity
-----
Capital Lease Obligations
€ 29.00M€ 26.80M€ 27.40M€ 26.70M€ 3.30M
Currency in EUR

Biotest Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis